For Immediate Release
June 23, 2022
NY State Medical Society Applauds FDA Decision to Order Juul E-Cigarettes Off the Market
Statement Attributable to:
Parag Mehta, MD
President, Medical Society of the State of New York
“The Medical Society of the State of New York (MSSNY) applauds today’s decision by the U.S. Food and Drug Administration (FDA) to order e-cigarette producer Juul—one of the leading manufacturers of e-cigarettes—to take its products off the market. This move followed the FDA’s two-year review process of Juul tobacco and menthol-flavored vaping products. MSSNY adopted policy in 2019 calling for the FDA to ensure that vaping products were only available by prescription, specifically for smokers who are trying to quit smoking.
“Today’s decision is another step in protecting our nation’s youth from using e-cigarettes. It will play a significant role in preventing tobacco companies from using e-cigarette products to addict yet another generation of children to nicotine. As physicians, we know the importance of developing healthy habits in childhood. Today’s decision is an important step in helping our children achieve wellness throughout their lives.
“The FDA had already banned sales of fruity and sweet flavors on concerns the products were being marketed to minors and it had already tightened its oversight of e-cigarette companies.”
# # #
Founded in 1807, the Medical Society of the State of New York is the state’s principal non-profit professional organization for physicians, residents and medical students of all specialties. Its mission is to represent the interests of patients and physicians to assure quality healthcare services for all.
Media Contact:
Roseann Raia
Communications / Marketing
Medical Society of the State of New York
865 Merrick Ave.
Westbury, New York
516-488-6100 ext 302
Share
This guideline provides recommendations for clinicians providing pain care, including those prescribing opioids, for outpatients aged ≥18 years. It updates the CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016 (MMWR Recomm Rep 2016;65[No. RR-1]:1–49) and includes recommendations for managing acute (duration of <1 month), subacute (duration of 1–3 months), and chronic (duration of >3 months) pain. The recommendations do not apply to pain related to sickle cell disease or cancer or to patients receiving palliative or end-of-life care [...]
-
The New York State Department of Health is reminding New Yorkers that the overuse and misuse of antibiotics are key factors leading to antibiotic resistance. So, while it is tempting to ask a health care provider for antibiotics to treat cold, flu, and other viral illness, it is best to leave such decisions to your provider, as antibiotics only work on bacterial infections. That's the message on a new poster the Department is making available to observe U.S. Antibiotic Awareness Week, which runs from November 18 to 24 [...]
he New York State Department of Health is reminding New Yorkers that the overuse and misuse of antibiotics are key factors leading to antibiotic resistance. So, while it is tempting to ask a health care provider for antibiotics to treat cold, flu, and other viral illness, it is best to leave such decisions to your provider, as antibiotics only work on bacterial infections. That's the message on a new poster the Department is making available to observe U.S. Antibiotic Awareness Week, which runs from November 18 to 24 [...]
-
As you are likely aware, there is increased circulation of several respiratory viruses in recent weeks, including RSV, the Flu and COVID 19, especially among our pediatric population. The Department of Health is monitoring regional hospital capacity and is engaging hospital and health care systems that may be seeing larger than normal patient volumes in their emergency departments and inpatient units. […]
